Skip to main content
43°
Light Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
113.13
+4.90 (+4.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
65
66
Next >
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
September 26, 2022
Via
Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
September 26, 2022
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19.
Via
Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
September 26, 2022
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the...
Via
Benzinga
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
September 26, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
Via
Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
September 26, 2022
Via
Benzinga
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.
Via
InvestorPlace
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Check Out What Whales Are Doing With BNTX
September 19, 2022
Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now?
Via
InvestorPlace
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo
Via
Benzinga
The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll
September 15, 2022
The companies recently launched their updated Covid booster shots.
Via
Investor's Business Daily
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022
From
Pfizer Inc.
Via
Business Wire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Via
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via
Benzinga
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters
September 02, 2022
These new shots target the BA.4 and BA.5 subvariants of omicron.
Via
Investor's Business Daily
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Via
Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
Health Canada has approved Moderna Inc's (NASDAQ:
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 01, 2022
From
Pfizer Inc.
Via
Business Wire
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Wall Street Journal
Via
Benzinga
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News
August 31, 2022
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...
Via
Benzinga
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 31, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters
August 31, 2022
Boosters are recommended two months out from the last shot.
Via
Investor's Business Daily
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30
August 30, 2022
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s
Via
Benzinga
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
August 30, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the...
Via
Benzinga
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
August 30, 2022
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
Via
Benzinga
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine
August 26, 2022
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.